Product Recalls in Rhode Island

Product recalls affecting Rhode Island — including food, drugs, consumer products, medical devices, and vehicles distributed to Rhode Island. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,544 recalls have been distributed to Rhode Island in the last 12 months.

47,970 total recalls
2,544 in last 12 months

Showing 36013620 of 47,970 recalls

DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Mylan Institutional, Inc.

Recalled Item: Levothyroxine Sodium Tablets Recalled by Mylan Institutional, Inc. Due to...

The Issue: Subpotent and Superpotent Drug

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine DR Capsules USP 60 mg Recalled by Rising Pharma Holding, Inc. Due...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Rising Pharma Holding,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 19, 2024· Rising Pharma Holding, Inc.

Recalled Item: Duloxetine Delayed-Release Capsules USP Recalled by Rising Pharma Holding,...

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
Medical DeviceNovember 19, 2024· Greiner Bio-One GmbH

Recalled Item: VACUETTE SAFELINK Recalled by Greiner Bio-One GmbH Due to The VACUETTE...

The Issue: The VACUETTE SAFELINK Holder with male luer lock may leak blood due to the...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceNovember 19, 2024· Baxter Healthcare Corporation

Recalled Item: Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 8)...

The Issue: Devices were identified as released after repair without full testing being...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
Medical DeviceNovember 19, 2024· Baxter Healthcare Corporation

Recalled Item: Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6)...

The Issue: Devices were identified as released after repair without full testing being...

Recommended Action: Stop using. Contact the manufacturer or your healthcare provider.

Class II — Potential Health HazardOngoing
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablet Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Endo USA, Inc.

Recalled Item: Clonazepam Orally Disintegrating Tablets Recalled by Endo USA, Inc. Due to...

The Issue: Labeling: Label Error on Declared Strength; Some cartons were incorrectly...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class I — Serious Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugNovember 18, 2024· Viatris Inc

Recalled Item: Levothyroxine Sodium Tablets USP Recalled by Viatris Inc Due to Superpotent...

The Issue: Superpotent Drug and Subpotent Drug: potency failures obtained

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund